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Abstract
Background: Endoscopic resection is accepted as the standard treatment for early mucosal gastric cancer, and its
indications have recently been expanded while its long-term outcomes are still unclear. Herein, we present a
didactic case of undifferentiated-type mucosal gastric cancer fulfilling the expanded indication and curative criteria
for endoscopic submucosal dissection (ESD), having synchronous multiple lymph node metastases.
Case presentation: A 40-year-old woman was found to have a Helicobacter pylori infection at a standard health
check with no abdominal symptoms. She received an upper gastrointestinal endoscopy and found to have an
undifferentiated-type mucosal gastric cancer with the size of 15 mm in diameter without ulceration, which fulfilled
the expanded indication for ESD. According to patient’s preference, we performed laparoscopy-assisted distal
gastrectomy with D1+ lymph node dissection, and routine pathological analysis revealed a predominantly signet
ring cell carcinoma limited to the mucosa without ulceration or any vessel involvement; on the other hand, 15
lymph node metastases were detected. Then, we added deep sectioning of the whole tumoral area at a thickness
of 20 μm and immunohistochemical analyses. As the result, an isolated lymphatic capillary involvement of the
extremely superficial submucosa was identified in a single histological section, and pathological diagnosis was
corrected to ly1. She received postoperative adjuvant chemotherapy with an S-1 oral agent and had no recurrence
under strict surveillance for 1 year postoperatively.
Conclusions: When we perform ESD for undifferentiated-type gastric cancer, deep sectioning of the whole tumoral
area into thin slices and immunohistochemical staining using D2-40 should be practically considered.
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Background
Endoscopic resection has been accepted as a standard
treatment for early mucosal gastric cancer, associated
with a very low incidence of lymph node metastasis [1].
According to recent Japanese gastric cancer treatment
guidelines [2, 3], the presence of differentiated-type muco-
sal gastric cancer up to 20 mm in diameter without ulcer-
ation is an absolute indication for endoscopic submucosal
dissection (ESD), while the presence of undifferentiated-
type mucosal gastric cancer up to 20 mm in diameter
without ulceration is specified as an expanded indication
for ESD.
Although the expanded indication for ESD for the
treatment of early gastric cancer is based on the assump-
tion of negligible lymph node involvement, the incidence
of lymph node metastasis in cases of early gastric cancer
with expanded indication is higher than that in cases
where there is an absolute indication for ESD [4]. In
contrast, studies have reported a comparable low risk of
lymph node metastasis in cases with an absolute indica-
tion for endoscopic resection, compared to cases with
expanded indication [5]. Moreover, ESD for expanded
indication is reported to be technically feasible from the
aspect of short-term outcome [6, 7]. In Japan, a phase II
clinical trial was recently conducted to evaluate the effi-
cacy of ESD for intramucosal gastric cancer of undiffer-
entiated type, with a primary end point of 5-year overall
survival [8]. At present, the use of ESD in cases with
expanded indication remains controversial in terms of
long-term outcome. Here, we report a case of undiffer-
entiated mucosal gastric cancer with multiple lymph
node metastases fulfilling the expanded curative criteria
for endoscopic resection according to routine patho-
logical analysis.
Case presentation
A 40-year-old woman was found to have a Helicobacter
pylori infection at a standard health check and was accord-
ingly referred to our hospital. An upper gastrointestinal
endoscopy demonstrated a 0-IIc-type lesion 15 mm in
diameter located at the lesser curvature of the middle gas-
tric body, without ulceration (Fig. 1). Histological analysis
of a biopsy specimen demonstrated a signet ring cell
carcinoma, while computed tomography revealed neither
enlarged lymph nodes nor distant metastases. Accordingly,
undifferentiated-type mucosal gastric cancer was diag-
nosed, with the possibility of lymph node metastasis con-
sidered very low. As the lesion fulfilled the expanded
indication for ESD according to the Japanese gastric cancer
treatment guidelines [3], we elected to perform ESD as rec-
ommended treatment. However, because the patient and
her family ultimately requested surgical treatment, we
therefore performed laparoscopy-assisted distal gastrec-
tomy with D1+ lymph node dissection without any intra-
operative complications. Macroscopically, the 0-IIc lesion
without lymph node metastasis was identified in the
resected specimen (Fig. 2).
Routine histological analysis of the resected specimen
with hematoxylin and eosin (H&E) staining revealed a
predominantly signet ring cell carcinoma of 15-mm
diameter limited to the mucosa, without lymphatic-
vascular capillary involvement or ulcerative components.
There were neither apparent findings outside the zone
of the tumoral area nor another malignant lesion in the
resected specimen. Multiple lymph node metastases of
the perigastric area were unexpectedly identified in 15 of
the 45 retrieved lymph nodes; therefore, the tumor was
classified as pathological stage IIB (T1a N3 M0).
Because of multiple lymph node metastases, the present
case was sufficiently unusual to prompt us to perform add-
itional deep sectioning of the whole tumoral area at a
thickness of 20 μm, and further analyses were performed
using H&E and D2-40 staining. The results of these ana-
lyses demonstrated that all cancer cells existed completely
limited to the mucosa, with immunohistochemical staining
for desmin and vimentin revealing no evidence of fibrosis
in the submucosal layer or deformity of the muscularis
mucosae. However, we finally identified isolated lymphatic
a b
Fig. 1 Upper gastrointestinal endoscopic findings. a The 0-IIc-type lesion with 15 mm in diameter was located on the lesser curvature of the middle
gastric body without ulceration (arrow). b A biopsy scar was found in the center of the lesion by endoscopy with indigo carmine
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capillary involvement of the extremely superficial sub-
mucosa in a single histological section (Fig. 3).
The postoperative course of this case was uneventful,
and the patient received postoperative adjuvant chemo-
therapy with an S-1 oral agent. At this moment, no re-
currence was observed following strict surveillance for
1 year postoperatively.
In general, further size and ulceration of early mucosal
gastric cancer are considered as risk factors for lymph
node metastasis. The rate of lymph node metastasis from
mucosal early gastric cancer has been reported to be as
high as 8 %, and the risk factors for lymph node metastasis
were tumor size and having ulceration in 148 cases, who
were diagnosed with early mucosal gastric cancer without
adaptation of endoscopic resection and underwent laparo-
scopic gastrectomy [4]. Hirasawa et al. reported that
tumor sizes greater than 21 mm, lymphatic-vascular capil-
lary involvement, and submucosal penetration were con-
sidered as risk factors for lymph node metastasis in a
series of 3843 cases diagnosed with undifferentiated-type
early gastric cancer who underwent gastrectomy [9]. Re-
cently, Pyo et al. demonstrated tumor sizes larger than
17 mm, elevated tumor type, and lymphatic-vascular in-
volvement to be significantly associated with lymph node
metastasis [10]. The present case would be a candidate for
curative resection with expanded criteria according to the
Japanese guidelines because of the identification of an
undifferentiated lesion with a diameter of 15 mm without
ulceration. However, postoperative histological analysis re-
vealed as many as 15 regional lymph node metastases in
our case, despite the absence of metastatic lymph nodes in
either preoperative analysis or intraoperative observations.
Synchronous lymph node metastasis has previously been
reported in a case fulfilling the expanded criteria for endo-
scopic resection [11]. In this report, the lesion was sliced
into 60 thin sections, and additional histological analysis
was performed using D2-40, desmin, Masson, and vimen-
tin immunohistochemistry. As the result, lymphatic vessel
involvement was identified in the deep mucosal layer, and
accordingly, the authors suggested that routine patho-
logical analyses for undifferentiated-type gastric cancer are
inadequate for determining curative resection. Sako et al.
reported an improvement in the diagnostic accuracy of
lymphatic vessel involvement by using an immunohisto-
chemical method with D2-40 in the pathological analysis
of early gastric cancer [12]. Furthermore, a correlation be-
tween lymph node micrometastasis and lymphatic inva-
sion has previously been reported, with micrometastasis
found to be more closely correlated with D2-40 than H&E
staining [13, 14]. There are some immunohistochemical
examinations for detecting lymphatic-vascular involve-
ment. Actually, D2-40 staining is the most powerful tool
a b
Fig. 2 Macroscopic findings of the resected specimen. a A 0-IIc-type lesion of 15-mm diameter without ulceration was detected, and clips were
applied to the oral side of the tumor. b Magnified view of the lesion (arrow)
ba
Fig. 3 Microscopic findings of the resected specimen. a H&E staining revealed all cancer cells were completely limited to the mucosa without
lymphatic-vascular capillary involvement or ulcerative components. b Immunohistochemical staining with D2-40 revealed isolated lymphatic
capillary involvement of the extreme superficial submucosa in just one histological section
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to detect lymphatic-vascular involvement. As for other
methods, lymphatic vessel endothelial hyaluronan
receptor-1 (LYVE-1) and platelet and endothelial cell ad-
hesion molecule 1 (PECAM1) are also available, but these
are less common. Therefore, we conducted additional
pathological analyses of deep-cut sections of the whole
tumoral area at 20-μm thickness using H&E and D2-40
staining to identify cancer cells in unexpected areas. Des-
pite tumoral depth in the remaining mucosa, we finally
identified isolated lymphatic capillary involvement in the
shallow submucosal layer in one histological section. Con-
sequently, gastrectomy with lymph node dissection could
contribute to a favorable outcome in this case.
Conclusions
The findings of this study indicate that intensive patho-
logical analyses using H&E and D2-40 staining in thin-cut
histological sections should be considered in cases of
undifferentiated-type gastric cancer, fulfilling the expanded
indication for endoscopic resection in order to detect
minute lymphatic capillary involvement.
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